Originally, ATXN2 was primarily investigated in the context of ALS, but subsequent research has highlighted its pathogenic involvement in FTLD, where mutant ATXN2 leads to the formation of poly(Q) bundles and aberrant modification of TDP-43 [107]. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.